Miura-Takahashi E, Tsudome R, Suematsu Y, Tachibana T, Kato Y, Kuwano T
Hypertens Res. 2024; 48(2):650-661.
PMID: 39394514
DOI: 10.1038/s41440-024-01934-x.
Chatterton C, Romero R, Jung E, Gallo D, Suksai M, Diaz-Primera R
J Matern Fetal Neonatal Med. 2023; 36(1):2183470.
PMID: 36997168
PMC: 10352993.
DOI: 10.1080/14767058.2023.2183470.
Yu Y, Gui X, Yu M, Huang W, Peng L, Dai J
Ann Transl Med. 2022; 10(14):797.
PMID: 35965810
PMC: 9372699.
DOI: 10.21037/atm-22-3215.
Zeng Y, Xue M, Zhang T, Sun S, Lin R, Li N
Exp Biol Med (Maywood). 2021; 246(21):2297-2306.
PMID: 34225474
PMC: 8581825.
DOI: 10.1177/15353702211027116.
Brusletto B, Loberg E, Hellerud B, Goverud I, Berg J, Olstad O
Front Cell Infect Microbiol. 2020; 10:42.
PMID: 32154187
PMC: 7045056.
DOI: 10.3389/fcimb.2020.00042.
Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis B.
Xie L, Liao G, Chen H, Xia M, Huang X, Fan R
BMC Infect Dis. 2019; 19(1):640.
PMID: 31324231
PMC: 6642508.
DOI: 10.1186/s12879-019-4261-3.
Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
Billiar I, Guardado J, Abdul-Malak O, Vodovotz Y, Billiar T, Namas R
J Surg Res. 2019; 244:23-33.
PMID: 31279260
PMC: 6815699.
DOI: 10.1016/j.jss.2019.05.057.
A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension.
Luk K, Ip C, Gong M, Wong S, Wu W, Dong M
J Geriatr Cardiol. 2018; 14(12):766-771.
PMID: 29581716
PMC: 5863055.
DOI: 10.11909/j.issn.1671-5411.2017.12.007.
Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.
Seo S, Yu J, Jenkins I, Leisenring W, Steven-Ayers T, Kuypers J
Biol Blood Marrow Transplant. 2017; 24(4):678-686.
PMID: 29223372
PMC: 5902640.
DOI: 10.1016/j.bbmt.2017.11.039.
IL-33 and the intestine: The good, the bad, and the inflammatory.
Hodzic Z, Schill E, Bolock A, Good M
Cytokine. 2017; 100:1-10.
PMID: 28687373
PMC: 5650929.
DOI: 10.1016/j.cyto.2017.06.017.
ST2/IL-33-Dependent Microglial Response Limits Acute Ischemic Brain Injury.
Yang Y, Liu H, Zhang H, Ye Q, Wang J, Yang B
J Neurosci. 2017; 37(18):4692-4704.
PMID: 28389473
PMC: 5426564.
DOI: 10.1523/JNEUROSCI.3233-16.2017.
Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.
Romero R, Chaemsaithong P, Tarca A, Korzeniewski S, Maymon E, Pacora P
J Matern Fetal Neonatal Med. 2017; 31(4):418-432.
PMID: 28114842
PMC: 5581264.
DOI: 10.1080/14767058.2017.1286319.
Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases.
Zhao J, Zhao Y
Crit Rev Immunol. 2016; 35(6):451-61.
PMID: 27279043
PMC: 5836295.
DOI: 10.1615/CritRevImmunol.2016015865.
Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection.
Huan S, Zhao J, Wang Z, Gao S, Wang K
BMC Infect Dis. 2016; 16:200.
PMID: 27180842
PMC: 4868038.
DOI: 10.1186/s12879-016-1543-x.
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant.
Rivera L, Siddaiah R, Oji-Mmuo C, Silveyra G, Silveyra P
Front Pediatr. 2016; 4:33.
PMID: 27065351
PMC: 4814627.
DOI: 10.3389/fped.2016.00033.
Expression of inhibitory regulators of innate immunity in patients with active tuberculosis.
Blok D, Kager L, Hoogendijk A, Lede I, Rahman W, Afroz R
BMC Infect Dis. 2015; 15:98.
PMID: 25887604
PMC: 4365962.
DOI: 10.1186/s12879-015-0833-z.
Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
Kim D, Baek S, Park M, Park K, Lee J, Park S
J Korean Med Sci. 2013; 28(8):1145-53.
PMID: 23960440
PMC: 3744701.
DOI: 10.3346/jkms.2013.28.8.1145.
Prognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome.
Bajwa E, Volk J, Christiani D, Harris R, Matthay M, Thompson B
Crit Care Med. 2013; 41(11):2521-31.
PMID: 23939353
PMC: 3812317.
DOI: 10.1097/CCM.0b013e3182978f91.
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.
Bergis D, Kassis V, Ranglack A, Koeberle V, Piiper A, Kronenberger B
Transl Oncol. 2013; 6(3):311-8.
PMID: 23730411
PMC: 3660800.
DOI: 10.1593/tlo.12418.
Soluble ST2, a modulator of the inflammatory response, in preterm and term labor.
Stampalija T, Chaiworapongsa T, Romero R, Tarca A, Bhatti G, Chiang P
J Matern Fetal Neonatal Med. 2013; 27(2):111-21.
PMID: 23688338
PMC: 4161022.
DOI: 10.3109/14767058.2013.806894.